T1与T2定量成像识别系统性结节病早期心脏受累
本研究纳入53例经活检证实的系统性结节病患者和36名健康对照,行心脏磁共振评估心功能、晚期钆增强及T1、T2定量成像;患者心肌原生T1和T2较对照组升高且鉴别健康与疾病的准确性高于标准诊断标准,治疗后原生T1和T2显著降低,提示T1与T2定量成像可能无创识别心脏受累及炎症活动。
要点
- 系统性结节病患者心肌原生T1和T2较健康对照升高,鉴别健康与疾病的AUC分别为0.96和0.89。
- 原生T1是独立鉴别指标,特异度90%、敏感度96%、准确率94%,优于标准诊断标准(AUC<0.67)。
- 接受抗炎治疗者原生T1和T2显著降低(z=-3.72和-2.88,P<.01),未治疗者无显著变化。
核心结论
- T1与T2定量心肌组织特征成像可能无创识别系统性结节病患者的心脏受累及心肌炎症活动。
研究设计与样本
- 连续纳入53例经活检证实的系统性结节病患者(21名男性,中位年龄45岁,四分位距22岁)和36名血压正常且既往健康的对照者(14名男性,中位年龄43岁,四分位距18岁),行心脏磁共振评估心功能、晚期钆增强及T1和T2定量成像;对40例患者进行随访(平均随访间隔144天±35天),其中18例因全身症状接受抗炎治疗;采用二元逻辑回归和受试者工作特征曲线分析鉴别健康与疾病,Wilcoxon符号秩检验评估治疗效应。
关键影像表现/征象
- 与对照组相比,患者心室容积更高、心肌原生T1和T2更高、纵向应变和射血分数更低(所有P<.05)。
- 患者心肌原生T1和T2区分对照组与患者的AUC分别为0.96和0.89,高于标准诊断标准的AUC<0.67。
- 原生T1是健康与疾病之间的独立鉴别指标(特异度90%,敏感度96%,准确率94%)。
诊断标准与关键数值
- 原生T1鉴别健康与疾病的特异度为90%、敏感度为96%、准确率为94%,AUC为0.96。
- 原生T2区分对照组与患者的AUC为0.89。
- 标准诊断标准区分对照组与患者的AUC<0.67。
临床应用与阅片要点
- T1与T2定量成像可能用于无创识别系统性结节病患者的心脏受累与心肌炎症活动。
- 作者指出未来将开展研究以确认其在风险分层和指导临床管理中的作用。
局限性
- 原文结论指出未来将开展研究以确认T1和T2定量成像在风险分层和指导临床管理中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine whether quantitative tissue characterization with T1 and T2 mapping supports recognition of myocardial involvement in patients with systemic sarcoidosis. Materials and Methods Fifty-three consecutive patients with a biopsy-proven extracardiac diagnosis of systemic sarcoidosis (21 men; median age, 45 years; interquartile range, 22 years) and 36 normotensive previously healthy control subjects (14 men; median age, 43 years; interquartile range, 18 years) underwent cardiovascular magnetic resonance imaging, which was performed to assess cardiac function and late gadolinium enhancement, and T1 and T2 mapping. A follow-up substudy was performed in 40 patients (mean follow-up interval, 144 days ± 35 [standard deviation]); of these 40 patients, 18 underwent anti-inflammatory treatment for systemic symptoms. Binary logistic regression and receiver operating characteristic curve analyses were used to assess discrimination between health and disease; Wilcoxon signed rank test was used to assess the effect of treatment. Results When compared with control subjects, patients had higher ventricular volume, higher myocardial native T1 and T2, and lower longitudinal strain and ejection fraction (P < .05 for all). Myocardial native T1 and T2 had higher discriminatory accuracy (area under the receiver operating characteristic curve [AUC]: 0.96 and 0.89, respectively) for separation between control subjects and patients when compared with the standard diagnostic criteria (AUC < 0.67). Native T1 was the independent discriminator between health and disease (specificity, 90%; sensitivity, 96%; accuracy, 94%). There was a significant reduction of native T1 and T2 in the patients who underwent treatment (z score: -3.72 and -2.88; P < .01) but not in the patients who did not (z score, -1.42 and -1.38; P > .15). Conclusion Quantitative myocardial tissue characterization with T1 and T2 mapping may enable noninvasive recognition of cardiac involvement and activity of myocardial inflammation in patients with systemic sarcoidosis. Future studies will be performed to confirm their role in risk stratification and guidance of clinical management. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Puntmann VO, Isted A, Hinojar R, et al. T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. Radiology. 2017. PMID: 28448233. doi:10.1148/radiol.2017162732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。